Cannabis prescribing without robust evidence ‘mirrors early trends in opioid use’

Current quality and safety requirements are not sufficient for medicinal cannabis products, say hospital pharmacists As concerns grow among health professionals about the way in which medicinal cannabis is prescribed and dispensed in Australia, Advanced Pharmacy Australia (AdPha) has added its voice, providing a submission to the TGA consultation on Reviewing the Safety and Regulatory Oversight